EQUILLIUM, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
EQUILLIUM, INC. (EQ) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $13.90 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-13
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $13.90M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $12.30M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.70M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $8.40M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $13.90M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $12.30M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $7.70M 10-K · filed 2026-03-25 |
| 2025-09-30 | $8.40M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.70M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $3.20M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.80M 10-K · filed 2025-03-27 |
| 2023-12-31 | $5.30M 10-K · filed 2024-03-25 |
| 2023-03-31 | $7.20M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.70M 10-K · filed 2023-03-23 |
| 2021-12-31 | $9.20M 10-K · filed 2022-03-23 |
| 2020-12-31 | $6.60M 10-K · filed 2021-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |